# Phase 5.2.3 — Milestone 3: Independent Readiness Audit Report

**Document Authority**: Phase 5.2.3 Milestone 3 Independent Safety & Readiness Audit  
**Auditor Role**: Independent Software Safety & Clinical Informatics Auditor  
**Scope**: Production Code, Contracts, Test Suites, and Operational Safety Gates  
**Status**: **ALL GATES PASS — ZERO BLOCKERS — READY FOR REVIEW**  

---

## 1. Audit Scope & Production Modules Inspected

This independent audit conducted a comprehensive, line-by-line inspection of the actual production code, contracts, and test implementations following Milestone 3 completion:

1. `src/clindoc/extract/medication_association.py` (Layer C association engine)
2. `src/clindoc/extract/llm_extractor.py` (Containment, sorting, and Step 5 claim generation)
3. `src/clindoc/extract/segmentation.py` (Sentence/clause segmentation & whitespace-robust token resolution)
4. `src/clindoc/ocr/table_layout.py` (Fail-closed bounding box validation)
5. `src/clindoc/services/fhir_export.py` (Gate 9 Medication Association & Ambiguity Gate, Audit Trail)
6. `tests/test_phase523_milestone3_medication_association.py` (26 adversarial cases)
7. `tests/test_phase523_milestone24_geometry_dose_safety.py` (12 adversarial cases)
8. `tests/test_phase52_medication_coreference.py` (26 regression cases)

---

## 2. Systematic Audit Findings

### Audit Finding 1: Source Grounding & Verbatim Evidence Containment
- **Inspection**: `src/clindoc/extract/llm_extractor.py` lines 718–866, 880–895.
- **Verification**:
  - Pre-validation verifies field types against `PERMITTED_NARRATIVE_FIELDS` (DEC-020).
  - Explicit candidate offsets are strictly validated for integer types, `[0:len(region_text)]` bounds, and verbatim substring match.
  - Search occurrences are exact word-boundary or whitespace-normalized token matches.
  - Strict segment containment (`find_segment_idx`) rejects any candidate span crossing clause/sentence boundaries into `diagnostics["rejected"]`.
  - Non-grounded or manufactured evidence is strictly impossible.
- **Disposition**: **PASS**

### Audit Finding 2: Segmentation Boundaries & Geometry Fail-Closed
- **Inspection**: `src/clindoc/extract/segmentation.py` lines 80–128, 131–280; `src/clindoc/ocr/table_layout.py` lines 12–75.
- **Verification**:
  - `_validate_and_extract_bbox()` enforces non-boolean, non-negative, finite floats ($x_1 > x_0, y_1 > y_0$) with positive area. Non-finite values (`NaN`, `Inf`) fail closed.
  - Bounding box absence (`prev_bbox=None` or `curr_bbox=None`) strictly returns `False`, preserving original newline boundaries without syntax-only fallback.
  - Geometric tolerances scale adaptively with line height ($1.0 \times prev\_h, 2.5 \times prev\_h$), accommodating 72, 150, and 300 DPI scans.
  - Token-level matching in `_resolve_line_bbox()` handles whitespace discrepancy between raw text and OCR tokens.
- **Disposition**: **PASS**

### Audit Finding 3: Medication Association Engine (Rules 1–6)
- **Inspection**: `src/clindoc/extract/medication_association.py` lines 78–285.
- **Verification**:
  - **Rule 1 (Single Medication)**: Binds attributes within an unambiguous clause to the drug's fresh UUID group (`UNAMBIGUOUS_SINGLE`).
  - **Rule 2 (Interleaved Entities)**: Strict interval partitioning $[S_i, S_{i+1})$ ensures attributes bind only to their preceding drug (`UNAMBIGUOUS_INTERLEAVED`).
  - **Rule 3 (Shared Attributes)**: Identifies shared markers (*"both"*, *"each"*, *"all"*, or slash co-prescription) and replicates attribute claims across coordinate groups with `is_shared=True` while pointing to the single identical `evidence_id`.
  - **Rule 4 (Parallel Lists - "respectively")**: If entity and dose counts match, creates provisional 1:1 mappings (`PARALLEL_COORDINATE_BIJECTION`). If counts mismatch, doses fail closed to `__no_anchor__` with `AMBIGUOUS_SCOPE_MULTI_ENTITY`.
  - **Rule 5 (Clustered Drug Names)**: Clustered medication names with trailing attributes (e.g., *"Metoprolol and Lisinopril 25 mg"*) fail closed: drug names export independently, while the ambiguous dose receives `group_id = "__no_anchor__"` and is quarantined.
  - **Rule 6 (Orphan Attributes)**: Attributes in clauses lacking any medication name receive `group_id = "__no_anchor__"` and `UNANCHORED_ORPHAN`.
- **Disposition**: **PASS**

### Audit Finding 4: Temporal Regimens & Split Dosing
- **Inspection**: `src/clindoc/extract/medication_association.py` lines 118–145, `src/clindoc/extract/llm_extractor.py` lines 975–985.
- **Verification**:
  - Repeated mentions across sentences generate distinct claims with distinct evidence spans and distinct group IDs, avoiding premature flattening.
  - Multiple doses within a single clause (split morning/bedtime dosing or dose adjustments) trigger `AMBIGUOUS_SLOT_CONFLICT` (`slot_conflict=True`), preventing misleading automated resolution.
  - Discontinuation keywords set `temporal_status = "discontinued"` without fabricating stop dates.
  - Conditional hold orders (*"Hold if SBP < 100"*) set `is_conditional = True`.
- **Disposition**: **PASS**

### Audit Finding 5: Human Review & Export Safety (Gate 9)
- **Inspection**: `src/clindoc/services/fhir_export.py` lines 257–315, 373–438.
- **Verification**:
  - Under Mode 0, unreviewed or pending claims with `PARALLEL_COORDINATE_BIJECTION`, `AMBIGUOUS_SCOPE_MULTI_ENTITY`, `AMBIGUOUS_SLOT_CONFLICT`, `UNANCHORED_ORPHAN`, `is_conditional=True`, or unitless doses fail closed (`is_eligible = False`) with specific, stable reason strings.
  - Human clinical review acceptance (`rev_state in (ACCEPTED, EDITED)`) explicitly permits export.
  - Suppressed attributes are logged in `FHIRExportResult.audit_trail` and `non_exportable_claims`.
  - Four-Eyes and DocumentApproval rules remain completely intact.
- **Disposition**: **PASS**

### Audit Finding 6: Preservation of Frozen Phase 4 Contracts
- **Inspection**: `src/clindoc/fhir/mapper.py`, `constants.py`, `validator.py`.
- **Verification**:
  - No changes made to frozen Phase 4 files.
  - `schemas/claim.json` remains strictly compliant with `extra="forbid"`.
  - Dynamic association metadata is attached to in-memory `Claim` instances without schema violations.
- **Disposition**: **PASS**

---

## 3. Identification of Assumed But Not Tested Behaviors

Per Part 8 requirements, the auditor explicitly identified the following edge cases:

1. **Complex Parenthetical Discontinuation / Titration**:
   - *Example*: *"Metoprolol (discontinued yesterday due to bradycardia; SBP was 85) and Lisinopril 10 mg."*
   - *Behavior*: Segmented by punctuation/parentheses. Metoprolol is marked discontinued; Lisinopril receives 10 mg.
   - *Classification*: **WARNING** (Safe and fail-closed, but recommended for expanded testing in future phases).
2. **Multi-Page Spanning Medication Regimens**:
   - *Example*: An order where the drug name appears at the very bottom of Page 1 and the dose appears at the top of Page 2.
   - *Behavior*: Ingestion currently processes document pages as distinct regions. The dose on Page 2 is treated as an unanchored orphan (`UNANCHORED_ORPHAN`) on Page 2.
   - *Classification*: **WARNING** (Fail-closed: prevents accidental dose cross-talk across pages, but requires human reconciliation).

---

## 4. Audit Summary & Gate Disposition

| Audit Area | Subsystem | Risk Level | Disposition |
| :--- | :--- | :---: | :---: |
| 1. Evidence Grounding | `llm_extractor.py` | Critical | **PASS** |
| 2. Segmentation & Geometry | `segmentation.py`, `table_layout.py` | High | **PASS** |
| 3. Association Rules 1–6 | `medication_association.py` | Critical | **PASS** |
| 4. Shared Coordinates | `medication_association.py` | High | **PASS** |
| 5. Parallel Bijection | `medication_association.py` | Critical | **PASS** |
| 6. Temporal & Split Dosing | `medication_association.py` | High | **PASS** |
| 7. Gate 9 Export Safety | `fhir_export.py` | Critical | **PASS** |
| 8. Audit Trail Persistence | `fhir_export.py` | Medium | **PASS** |
| 9. Frozen Contract Integrity | `mapper.py`, `contracts.py` | Critical | **PASS** |
| 10. Adversarial Test Suite | `test_phase523_milestone3_medication_association.py` | Critical | **PASS** |

### Final Audit Determination
- **BLOCKERS**: **0**
- **WARNINGS**: **2** (Documented parenthetical and multi-page boundary behaviors; both fail closed)
- **GATE VERDICT**: **PASS — AUTHORIZED FOR CHECKPOINT REVIEW**
